<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD with MathML3 v1.1 20151215//EN" "JATS-journalpublishing1-mathml3.dtd">
<article dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
    <front>
        <journal-meta>
            <journal-id></journal-id> 
            <issn></issn>
        </journal-meta>
        <article-meta>
            <title-group>
                <article-title></article-title>
            </title-group>
            <pub-date>
                <year></year>
            </pub-date>
        </article-meta>
    </front>
    <back>
        <ref-list>
            <ref id="b1">
		        <label>1. </label>	
                <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Bonkat</surname>
                            <given-names>GC</given-names>
                        </name>, 
                        <name>
                            <surname>Pickard</surname>
                            <given-names>RC</given-names>
                        </name>, 
                        <name>
                            <surname>Bartoletti</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>Bruyère</surname>
                            <given-names>F</given-names>
                        </name>, 
                        <name>
                            <surname>Geerlings</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Wagenlehner</surname>
                            <given-names>F</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>. 
                    <source>Guidelines on Urological Infections 2017. European Association of Urology</source>. 
                    [<date-in-citation content-type="access-date">cited 2017 Sep 7</date-in-citation>]. 
                    <comment>Available from: <uri>http://uroweb.org/guideline/urological-infections/</uri></comment>.
                </mixed-citation>
            </ref>
            <ref id="b2">
		        <label>2. </label>
                <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Hooton</surname>
                            <given-names>TM</given-names>
                        </name>, 
                        <name>
                            <surname>Gupta</surname>
                            <given-names>K</given-names>
                        </name>
                    </person-group>. 
                    <chapter-title>Acute Complicated cystitis and pyelonephritis</chapter-title>. In: 
                    <person-group person-group-type="author">
                        <name>
                            <surname>Bloom </surname>
                            <given-names>A</given-names>
                        </name> 
                    </person-group>. 
                    <source>UpToDate</source>.
                    [<date-in-citation content-type="access-date">cited 2017 Sep 15</date-in-citation>]. 
                    <comment>Available from: <uri>https://www.uptodate.com/contents/acute-complicated-cystitis-and</uri></comment>.
                </mixed-citation>
            </ref>
            <ref id="b3">
		        <label>3. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Hooton</surname>
                            <given-names>TM</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Clinical practice. Uncomplicated urinary tract infection</article-title>.
                    <source>N Engl J Med</source>. 
                    <year>2012</year>
                    <month>Mar</month>;
                    <volume>366</volume>(
                    <issue>11</issue>):
                    <fpage>1028</fpage>–
                    <lpage>37</lpage>. 
                    <pub-id pub-id-type="doi">10.1056/NEJMcp1104429</pub-id>
                    <pub-id pub-id-type="pmid">22417256</pub-id>
                    <issn>0028-4793</issn>
                </mixed-citation>
            </ref>
            <ref id="b4">
		        <label>4. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Tandogdu</surname>
                            <given-names>Z</given-names>
                        </name>, 
                        <name>
                            <surname>Wagenlehner</surname>
                            <given-names>FM</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Global epidemiology of urinary tract infections</article-title>.
                    <source>Curr Opin Infect Dis</source>. 
                    <year>2016</year>
                    <month>Feb</month>;
                    <volume>29</volume>(
                    <issue>1</issue>):
                    <fpage>73</fpage>–
                    <lpage>9</lpage>. 
                    <pub-id pub-id-type="doi">10.1097/QCO.0000000000000228</pub-id>
                    <pub-id pub-id-type="pmid">26694621</pub-id>
                    <issn>0951-7375</issn> 
                </mixed-citation>
            </ref>
            <ref id="b5">
		        <label>5. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Gupta</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <name>
                            <surname>Hooton</surname>
                            <given-names>TM</given-names>
                        </name>, 
                        <name>
                            <surname>Naber</surname>
                            <given-names>KG</given-names>
                        </name>, 
                        <name>
                            <surname>Wullt</surname>
                            <given-names>B</given-names>
                        </name>, 
                        <name>
                            <surname>Colgan</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>Miller</surname>
                            <given-names>LG</given-names>
                        </name>, 
                        <etal>et al</etal>; 
                        <collab>Infectious Diseases Society of America</collab>; 
                        <collab>European Society for Microbiology and Infectious Diseases</collab>
                    </person-group>. 
                    <article-title>International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases</article-title>.
                    <source>Clin Infect Dis</source>. 
                    <year>2011</year>
                    <month>Mar</month>;
                    <volume>52</volume>(
                    <issue>5</issue>):
                    <fpage>e103</fpage>–
                    <lpage>20</lpage>. 
                    <pub-id pub-id-type="doi">10.1093/cid/ciq257</pub-id>
                    <pub-id pub-id-type="pmid">21292654</pub-id>
                    <issn>1058-4838</issn>
                </mixed-citation>
            </ref>
            <ref id="b6">
		        <label>6. </label>
                <mixed-citation publication-type="book-chapter">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Štrumbelj</surname>
                            <given-names>I</given-names>
                        </name>, 
                        <name>
                            <surname>Pirš</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Berce</surname>
                            <given-names>I</given-names>
                        </name>, 
                        <name>
                            <surname>Fišer</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Golle</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Harlander</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>. 
                    <chapter-title>Občutljivost pogostih bakterij za antbiotike v Sloveniji po podatkih SKIJOP, 2017-2016</chapter-title>. In: 
                        <person-group person-group-type="editor">
                            <name><surname>Beović</surname>
                                <given-names>B</given-names></name>,
                            <name><surname>Lejko Zupanc</surname>
                                <given-names>T</given-names></name>,
                            <name><surname>Tomažič</surname>
                                <given-names>J</given-names></name>
                            <role>eds</role>
                        </person-group>. 
                        <source>Stopenjska diagnostika in zdravljenje pogostih okužb</source>.
                        <publisher-loc>Ljubljana</publisher-loc>:
                        <publisher-name>Sekcija za protimikrobno zdravljenje SZD</publisher-name>;
                        <year>2017</year>. pp. 
                        <fpage>43</fpage>-
                        <lpage>52</lpage>. 
                </mixed-citation>
            </ref>
            <ref id="b7">
		        <label>7. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Warren</surname>
                            <given-names>JW</given-names>
                        </name>, 
                        <name>
                            <surname>Abrutyn</surname>
                            <given-names>E</given-names>
                        </name>, 
                        <name>
                            <surname>Hebel</surname>
                            <given-names>JR</given-names>
                        </name>, 
                        <name>
                            <surname>Johnson</surname>
                            <given-names>JR</given-names>
                        </name>, 
                        <name>
                            <surname>Schaeffer</surname>
                            <given-names>AJ</given-names>
                        </name>, 
                        <name>
                            <surname>Stamm</surname>
                            <given-names>WE</given-names>
                        </name>; 
                        <collab>Infectious Diseases Society of America (IDSA)</collab>
                    </person-group>. 
                    <article-title>Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women</article-title>.
                    <source>Clin Infect Dis</source>. 
                    <year>1999</year>
                    <month>Oct</month>;
                    <volume>29</volume>(
                    <issue>4</issue>):
                    <fpage>745</fpage>–
                    <lpage>58</lpage>. 
                    <pub-id pub-id-type="doi">10.1086/520427</pub-id>
                    <pub-id pub-id-type="pmid">10589881</pub-id>
                    <issn>1058-4838</issn>
                </mixed-citation>
            </ref>
            <ref id="b8">
		        <label>8. </label>
                <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <collab>The European Committee on Antimicrobial Susceptibility Testing</collab>
                    </person-group>. 
                    <source>Breakpoint tables for interpretation of MICs and zone diameters. Version 8.0, 2018. EUCAST</source>.
                    <year>2018</year>. 
                    [<date-in-citation content-type="access-date">cited 2018 Mar 11</date-in-citation>]. 
                    <comment>Available from: <uri>http://www.eucast.org/clinical_breakpoints/</uri></comment>.
                </mixed-citation>
            </ref>
            <ref id="b9">
                <label>9. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Paterson</surname>
                            <given-names>DL</given-names>
                        </name>
                    </person-group>. 
                    <article-title>"Collateral damage" from cephalosporin or quinolone antibiotic therapy</article-title>. 
                        <source>Clin Infect Dis</source>. 
                        <year>2004</year>
                        <month>Oct</month>;
                        <volume>29</volume>(
                        <issue>Supplement_4</issue>):
                        <fpage>S341</fpage>–
                        <lpage>5</lpage>. 
                        <pub-id pub-id-type="doi">10.1086/382690</pub-id>
                        <pub-id pub-id-type="pmid">15127367</pub-id>
                        <issn>1058-4838</issn> 
                </mixed-citation>
            </ref>
            <ref id="b10">
                <label>10. </label>
                <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <collab>The European Committee on Antimicrobial Susceptibility Testing</collab>.
                    </person-group>. 
                    <article-title>EUCAST breakpoints for oral cephalosporins. Guidance Document.</article-title>. 
                    <year>2012</year>. 
                    [<date-in-citation content-type="access-date">cited 2018 Mar 11</date-in-citation>]. 
                    <comment>Available from: <uri>http://www.eucast.org/guidance_documents/</uri></comment>.
                </mixed-citation>
            </ref>
            <ref id="b11">
                <label>11. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Jorgensen</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Zurayk</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Yeung</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Terry</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Dunn</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Nieberg</surname>
                            <given-names>P</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Risk factors for early return visits to the emergency department in patients with urinary tract infection</article-title>. 
                    <source>Am J Emerg Med</source>. 
                    <year>2018</year>
                    <month>Jan</month>;
                    <volume>36</volume>(
                    <issue>1</issue>):
                    <fpage>12</fpage>–
                    <lpage>7</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.ajem.2017.06.041</pub-id>
                    <pub-id pub-id-type="pmid">28655424</pub-id>
                    <issn>0735-6757</issn>
                </mixed-citation>
            </ref>
            <ref id="b12">
                <label>12. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Vahlensieck</surname>
                            <given-names>W</given-names>
                        </name>, 
                        <name>
                            <surname>Perepanova</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <name>
                            <surname>Bjerklund Johansen</surname>
                            <given-names>TE</given-names>
                        </name>, 
                        <name>
                            <surname>Tenke</surname>
                            <given-names>P</given-names>
                        </name>, 
                        <name>
                            <surname>Naber</surname>
                            <given-names>KG</given-names>
                        </name>, 
                        <name>
                            <surname>Wagenlehner</surname>
                            <given-names>FM</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Management of uncomplicated recurrent urinary tract infections</article-title>.
                    <source>Eur Urol Suppl</source>. 
                    <year>2016</year>;
                    <volume>15</volume>(
                    <issue>4</issue>):
                    <fpage>95</fpage>–
                    <lpage>101</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.eursup.2016.04.007</pub-id>
                    <issn>1569-9056</issn>
                </mixed-citation>
            </ref>
            <ref id="b13"> 
                <label>13. </label>
                <mixed-citation publication-type="webpage"> 
                    <person-group person-group-type="author">
                        <name>
                            <surname>Bodmann</surname>
                            <given-names>K</given-names> 
                        </name>, 
                        <name>
                            <surname>Grabein</surname>
                            <given-names>B</given-names>
                        </name>, 
                        <name>
                            <surname>Kresken</surname> 
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Derendorf</surname>
                            <given-names>H</given-names>
                        </name>, 
                        <name>
                            <surname>Stahlmann</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>Ott</surname>
                            <given-names>S</given-names>
                        </name>;
                        <collab>Paul-Ehrlich-Gesellschaft für Chemotherapie e.V</collab>
                        <etal>et al</etal>
                    </person-group>. 
                    <article-title>Kalkulierte parenterale Initialtherapie bakterieller Erkrankungen bei Erwachsenen – Update</article-title>.
                    <year>2018</year>.
                    [<date-in-citation content-type="access-date">cited 2019 Apr 1</date-in-citation>]. 
                    <comment>Available from: <uri>https://www.awmf.org/uploads/tx_szleitlinien/S82-006l_S2k_Parenterale_Antibiotika_2018-1.pdf</uri></comment>.
                </mixed-citation>
            </ref>
        </ref-list>
    </back>
</article>
